drugset / Trial / NCT06685692
A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)
Non-randomizedSequentialOpen-labelTreatment
Summary
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Moderate Alcohol Associated Hepatitis (Part 1)
Timeline
- Start
- 2024-11-04
- Primary completion
- 2025-06-18
- Completion
- 2025-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACLOPROXALAP | Other / unclassified | 125 mg | — |
| Subject | ACLOPROXALAP | Other / unclassified | 250 mg | — |